Open Orphan (ORPH) is a specialist Contract Research Organisation (CRO) offering pharmaceutical services relating to orphan and emerging therapies, and is pioneer in the testing of vaccines and anti-viral treatments through the use of human viral challenge (HVC) studies. FY19 financial results refl
24 Jun 2020
Open Orphan: Focused on a buoyant outlook
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Open Orphan: Focused on a buoyant outlook
hVIVO plc (HVO:LON) | 28.8 0.1 0.9% | Mkt Cap: 195.6m
- Published:
24 Jun 2020 -
Author:
Emma Ulker -
Pages:
3
Open Orphan (ORPH) is a specialist Contract Research Organisation (CRO) offering pharmaceutical services relating to orphan and emerging therapies, and is pioneer in the testing of vaccines and anti-viral treatments through the use of human viral challenge (HVC) studies. FY19 financial results refl